Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias
NCT ID: NCT03436251
Last Updated: 2021-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
53 participants
INTERVENTIONAL
2018-01-28
2020-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Mild local Hyperthermia with a certain temperature range has been successfully used in the treatment of some diseases. It has been utilised in the treatment of some neoplasm, fungal and HPV infections. Investigators' study found that local hyperthermia at 44°C could cleared HPV in more than half of the patients with plantar warts. Investigators also note the fact that in patients with multiple lesions, the clearance of the target lesion is commonly followed by clearance of other distant lesions, a phenomenon suggesting that local hyperthermia could aid in establishing a specific immune response to eliminate HPV.So the purpose of the study is to evaluation local hyperthermia in the treatment of cervical intraepithelial neoplasias grade I and II after 3 months, with positive high-risk type HPVs, and patients with positive testing for high risk HPVs. Appropriate control arms were designed for different conditions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Local Hyperthermia for the Treatment of Cervical Persistent High-risk Infection
NCT07059819
Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device
NCT03429582
MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer
NCT03977311
Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive Women
NCT01298596
Hyperthermia Combined Brachytherapy in CCU
NCT01474356
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Local Hyperthermia at 44℃ for HPV+/CIN-1
Local hyperthermia at 44℃ for 30 mins on cervical region, at days of 1,2,3 and 17, 18. HPV+ and normal cytology or HPV+/CIN-1
Local Hyperthermia at 44℃
As an experimental arm, for patients with HPV+/CIN-1/CIN2 or HPV+ with normal cytology
local hyperthermia at 37℃ for 30 mins
HPV+/CIN-1
Local Hyperthermia at 37℃
As a control, for patients with HPV+/CIN-1 or HPV+ with normal cytology, hyperthermia at 37℃ is applied
coniztion of the cervix treatment
coniztion of cervix for HPV+/CIN2, including LEEP or cold knife coniztion
LEEP or cold knife
For patients with HPV+ / CIN-2
Local Hyperthermia at 44℃ for CIN2/HPV+
Local hyperthermia at 44℃ for 30 mins at days of 1,2,3 and 17, 18. HPV+ and CIN2.
Local Hyperthermia at 44℃
As an experimental arm, for patients with HPV+/CIN-1/CIN2 or HPV+ with normal cytology
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Local Hyperthermia at 37℃
As a control, for patients with HPV+/CIN-1 or HPV+ with normal cytology, hyperthermia at 37℃ is applied
LEEP or cold knife
For patients with HPV+ / CIN-2
Local Hyperthermia at 44℃
As an experimental arm, for patients with HPV+/CIN-1/CIN2 or HPV+ with normal cytology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Hospital of China Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gao Xinghua
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xinghua Gao
Role: STUDY_DIRECTOR
First Hospital of China Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yang Yang
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yang Y, Zhang L, Zhang Y, Huo W, Qi R, Guo H, Li X, Wu X, Bai F, Liu K, Qiao Y, Piguet V, Croitoru D, Chen HD, Gao XH. Local Hyperthermia at 44 degrees C Is Effective in Clearing Cervical High-Risk Human Papillomaviruses: A Proof-of-Concept, Randomized Controlled Clinical Trial. Clin Infect Dis. 2021 Nov 2;73(9):1642-1649. doi: 10.1093/cid/ciab369.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HH20170606
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.